These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 25895705)

  • 1. The SVZ and Its Relationship to Stem Cell Based Neuro-oncogenesis.
    Kusne Y; Sanai N
    Adv Exp Med Biol; 2015; 853():23-32. PubMed ID: 25895705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A hypothesis: neural glial cells, neural stem cells and tumor stem cells transform each other depending on the micro-ecological environment].
    Huang Q; DU ZW
    Zhonghua Zhong Liu Za Zhi; 2010 Jan; 32(1):76-8. PubMed ID: 20211077
    [No Abstract]   [Full Text] [Related]  

  • 3. New advances of microRNAs in glioma stem cells, with special emphasis on aberrant methylation of microRNAs.
    Zhao B; Bian EB; Li J; Li J
    J Cell Physiol; 2014 Sep; 229(9):1141-7. PubMed ID: 24374932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinicopathological significance of expression of nestin, a neural stem/progenitor cell marker, in human glioma tissue.
    Tomita T; Akimoto J; Haraoka J; Kudo M
    Brain Tumor Pathol; 2014 Jul; 31(3):162-71. PubMed ID: 24202294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stem cells in brain tumorigenesis and their impact on therapy.
    Cardona AF; Balañá C; Torres D; Becerra H; Ortíz LD; Fadul CE
    Curr Stem Cell Res Ther; 2011 Dec; 6(4):339-49. PubMed ID: 21466481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The potential origin of glioblastoma initiating cells.
    Chesler DA; Berger MS; Quinones-Hinojosa A
    Front Biosci (Schol Ed); 2012 Jan; 4(1):190-205. PubMed ID: 22202053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristics of glioma stem cells.
    Sampetrean O; Saya H
    Brain Tumor Pathol; 2013 Oct; 30(4):209-14. PubMed ID: 23584571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glial progenitors as targets for transformation in glioma.
    Ilkhanizadeh S; Lau J; Huang M; Foster DJ; Wong R; Frantz A; Wang S; Weiss WA; Persson AI
    Adv Cancer Res; 2014; 121():1-65. PubMed ID: 24889528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The neural stem cell fate determinant TLX promotes tumorigenesis and genesis of cells resembling glioma stem cells.
    Park HJ; Kim JK; Jeon HM; Oh SY; Kim SH; Nam DH; Kim H
    Mol Cells; 2010 Nov; 30(5):403-8. PubMed ID: 20814749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunobiology and immunotherapeutic targeting of glioma stem cells.
    Madany M; Thomas TM; Edwards L; Yu JS
    Adv Exp Med Biol; 2015; 853():139-66. PubMed ID: 25895711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical relevance of tumor cells with stem-like properties in pediatric brain tumors.
    Thirant C; Bessette B; Varlet P; Puget S; Cadusseau J; Tavares Sdos R; Studler JM; Silvestre DC; Susini A; Villa C; Miquel C; Bogeas A; Surena AL; Dias-Morais A; Léonard N; Pflumio F; Bièche I; Boussin FD; Sainte-Rose C; Grill J; Daumas-Duport C; Chneiweiss H; Junier MP
    PLoS One; 2011 Jan; 6(1):e16375. PubMed ID: 21297991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary brain tumors, neural stem cell, and brain tumor cancer cells: where is the link?
    Germano I; Swiss V; Casaccia P
    Neuropharmacology; 2010 May; 58(6):903-10. PubMed ID: 20045420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantification, self-renewal, and genetic tracing of FL1⁺ tumor-initiating cells in a large cohort of human gliomas.
    Clément-Schatlo V; Marino D; Burkhardt K; Teta P; Leyvraz F; Schatlo B; Frank S; Schaller K; Castella V; Radovanovic I
    Neuro Oncol; 2012 Jun; 14(6):720-35. PubMed ID: 22584872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The origins of glioma: E Pluribus Unum?
    Siebzehnrubl FA; Reynolds BA; Vescovi A; Steindler DA; Deleyrolle LP
    Glia; 2011 Aug; 59(8):1135-47. PubMed ID: 21351156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell of origin for malignant gliomas and its implication in therapeutic development.
    Zong H; Parada LF; Baker SJ
    Cold Spring Harb Perspect Biol; 2015 Jan; 7(5):. PubMed ID: 25635044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glioma stem cell signaling: therapeutic opportunities and challenges.
    Dietrich J; Diamond EL; Kesari S
    Expert Rev Anticancer Ther; 2010 May; 10(5):709-22. PubMed ID: 20470003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of p53 cooperates with K-ras activation to induce glioma formation in a region-independent manner.
    Muñoz DM; Tung T; Agnihotri S; Singh S; Guha A; Zadeh G; Hawkins C
    Glia; 2013 Nov; 61(11):1862-72. PubMed ID: 24038521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brain tumor stem cells.
    Xie Z
    Neurochem Res; 2009 Dec; 34(12):2055-66. PubMed ID: 19856100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heterogeneous cellular origins for glioma in murine model.
    Jandial R; Chen MY
    Neurosurgery; 2013 Apr; 72(4):N20. PubMed ID: 23511833
    [No Abstract]   [Full Text] [Related]  

  • 20. MicroRNA-218 inhibits glioma invasion, migration, proliferation, and cancer stem-like cell self-renewal by targeting the polycomb group gene Bmi1.
    Tu Y; Gao X; Li G; Fu H; Cui D; Liu H; Jin W; Zhang Y
    Cancer Res; 2013 Oct; 73(19):6046-55. PubMed ID: 23950210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.